Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at Nasdaq Investor Conference Transcript

Dec 07, 2022 / 02:00PM GMT
Release Date Price: $38.2 (+0.45%)
Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst

All right. Good afternoon, everyone. I'm Andrew Galler, one of the biotech analysts in Morgan Stanley. And I'm pleased to be joined today by Brett Monia, President and CEO of Ionis. Brett, thanks for joining us today.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thanks, Andrew. It's great to be here.

Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst

And I just wanted to jump into a quick disclosure statement and then we can kick it off with Q&A. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, we can get into it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot